855 Pill - gray capsule/oblong, 12mm
Pill with imprint 855 is Gray, Capsule/Oblong and has been identified as Minocycline Hydrochloride 75 mg. It is supplied by Sun Pharmaceuticals Industries Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bartonellosis; Actinomycosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 855
Minocycline Hydrochloride
- Imprint
- 855
- Strength
- 75 mg
- Color
- Gray
- Size
- 12.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceuticals Industries Inc.
- National Drug Code (NDC)
- 57664-0855
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
povidone,
sodium starch glycolate type A potato,
silicon dioxide,
magnesium stearate,
hypromelloses,
titanium dioxide,
polyethylene glycol,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "855"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (562)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline (Oral) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Dynacin, Solodyn, Minolira, ... +2 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minolira, Minocin for Injection, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
